Nursing · Independent exam preparation
Certified Nephrology Nurse Examination (CNN) Study Guide
Practise CKD assessment, urgent kidney replacement decisions, PD infection recognition, home hemodialysis safety, and transplant care for NNCC's CNN examination.
By CertMedbry · Updated 28 October 2026
Learn to distinguish chronic kidney disease from acute injury, recognize urgent treatment needs, investigate dialysis complications, and support safe home therapy and transplant care. This guide follows NNCC's September 1, 2026 CNN specifications for registered nurses. Its 60 selected concepts emphasize clinical reasoning across all five domains; the official outline defines the full examination scope. The accompanying questions and flashcards are independently authored learning materials.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which credential and jurisdiction does this guide address?
This guide addresses NNCC's Certified Nephrology Nurse Examination, abbreviated CNN. The published eligibility pathway requires a full, unrestricted registered nurse license in the United States or its territories. CNN-NP and CDN have separate examinations and should not be treated as alternate names for CNN.
CNN — Nephrology Nursing Certification Commission · Certification Examination Application Booklet
How many questions are there, and how long is the examination?
NNCC states that CNN contains 150 questions with a three-hour testing period.
CNN — Nephrology Nursing Certification Commission · New Test Blueprint: Certified Nephrology Nurse (CNN) Examination
What delivery method and item styles are described by NNCC?
NNCC's materials reference computer-based testing. Its examination advice describes reading four answer choices, and its official practice test uses multiple-choice questions. The questions here are independent four-option, single-best-answer drills.
Which blueprint applies to this guide?
The CNN Test Specifications were revised April 2026 and became effective September 1, 2026. The matching blueprint distributes 150 items across five domains. The application booklet is revised June 2026. The January announcement's broader Summer 2026 wording is superseded for blueprint timing by the specifications' precise effective date.
Certified Nephrology Nurse Examination (CNN): Weights for Blueprint Categories · New Test Blueprint: Certified Nephrology Nurse (CNN) Examination · Certification Examination Application Booklet · Important Information Regarding CNN and CDN Examination Changes
How are the official domains weighted?
Concepts of Kidney Disease Across the Life Span accounts for 30%; Acute In-patient Therapies, 25%; Peritoneal Dialysis, 20%; Home Hemodialysis, 15%; and Transplant, 10%. This guide allocates 18, 15, 12, 9, and 6 concepts respectively. Each 20-item practice set uses 6, 5, 4, 3, and 2 items respectively.
Certified Nephrology Nurse Examination (CNN): Weights for Blueprint Categories
What cross-cutting objectives should preparation include?
NNCC assigns 20% to pathology and complications, 21% to interventions, 11% to physiological and technical principles, 15% to teaching, 12% to medication administration, 8% to infection control, and 13% to collaboration, psychosocial and cultural considerations, staff development, and quality improvement. These objectives cross the five content domains.
Certified Nephrology Nurse Examination (CNN): Weights for Blueprint Categories
What passing standard does NNCC publish?
NNCC states a standard score of 95, achieved by answering 70% of test questions correctly. These independently authored drills do not reproduce NNCC scoring or predict examination success.
How should candidates use this selective guide and its clinical references?
Use the official outline as the full scope and this guide to practise selected decisions within it. Clinical recommendations come from the cited clinical authorities. KDIGO's AKI guideline page distinguishes the published 2012 guideline from the 2026 public-review draft under preparation. The AKI lessons here use the published 2012 recommendations; draft recommendations are not final guidance.
Certified Nephrology Nurse Examination (CNN): Weights for Blueprint Categories · Acute Kidney Injury and Acute Kidney Disease — KDIGO · KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
The Certified Nephrology Nurse Examination assesses proficient registered nursing practice across nephrology settings. CNN-NP is a separate nurse practitioner examination, and CDN is a separate dialysis nursing credential. This guide consistently prepares for CNN.
Outline used: NNCC CNN Test Specifications revised April 2026, effective September 1, 2026; current CNN Test Blueprint and Certification Examination Application Booklet revised June 2026. Verified for the user-facing date October 11, 2026. The workbook label 'Nephrology Nursing Certification (CNN)' maps to the official Certified Nephrology Nurse Examination (CNN); the assigned canonical slug is preserved.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Concepts of Kidney Disease Across the Life Span30%
1.When does reduced kidney function establish CKD?
Chronic kidney disease requires abnormalities of kidney structure or function, with implications for health, present for at least three months. A persistently reduced estimated glomerular filtration rate below 60 mL/min/1.73 m² can establish CKD; persistent markers of kidney damage can establish it even with higher filtration. Historical laboratory results, imaging, pathology, and clinical history help establish chronicity. One abnormal result during acute illness cannot independently distinguish CKD from acute kidney injury.
Apply it
A patient with gastroenteritis has an eGFR of 48 and no previous results. Assess hydration and acute illness, review earlier records, and arrange reassessment rather than immediately labeling the patient as having established CKD.
Common pitfall: Do not equate one low eGFR with chronic disease. Conversely, a preserved eGFR does not exclude CKD when persistent kidney damage is present.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
2.How does cause–GFR–albuminuria classification refine risk?
CKD classification combines cause, GFR category, and albuminuria category. GFR categories are G1 ≥90, G2 60–89, G3a 45–59, G3b 30–44, G4 15–29, and G5 <15 mL/min/1.73 m². Urine albumin-to-creatinine ratio categories are A1 <30, A2 30–300, and A3 >300 mg/g. Higher albuminuria generally adds kidney and cardiovascular risk at a given GFR. G1 or G2 alone does not establish CKD: another marker of kidney damage must be present for at least three months. Cause is specified separately because it guides evaluation and management.
Apply it
An adult with established CKD, eGFR 50 mL/min/1.73 m², and ACR 650 mg/g is classified as G3a A3; document the established cause separately. Another adult with the same eGFR and ACR 12 mg/g is G3a A1 and generally has lower risk.
Common pitfall: Do not combine G3a and G3b into an undifferentiated category or treat G1 or G2 as proof of CKD without persistent kidney damage. A GFR category alone is not a complete risk description.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
3.Why should an elevated urine ACR be confirmed?
Urine albumin-to-creatinine ratio estimates albumin loss while accounting for urine concentration, making it more informative than urine albumin concentration alone. Albumin excretion varies, however, and exercise, infection, menstruation, or other transient conditions can distort interpretation. An elevated random ACR should generally be confirmed with a subsequent first-morning sample when feasible. Confirmation separates persistent kidney damage from a temporary finding and provides a more dependable baseline for monitoring response and progression.
Apply it
A runner provides a random urine sample after a strenuous race and has an elevated ACR. Arrange confirmation under stable conditions with a first-morning specimen before treating the isolated result as persistent albuminuria.
Common pitfall: Neither a concentrated urine sample nor a single abnormal dipstick establishes sustained albuminuria. Consider temporary influences and use quantitative confirmation to support classification.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
4.When can creatinine-based eGFR mislead?
Serum creatinine reflects both kidney clearance and creatinine generation, which depends partly on muscle mass. Marked muscle wasting can produce a reassuring creatinine despite impaired filtration, while unusually high muscle mass can have the opposite effect. When available, combined creatinine–cystatin C estimation can improve assessment when accuracy affects a clinical decision. Cystatin C also has non-GFR influences, so discordant estimates require clinical interpretation rather than automatic acceptance of whichever result appears more favorable.
Apply it
An older adult with major muscle loss has a low serum creatinine, but medication toxicity is suspected. Ask whether a combined creatinine–cystatin C estimate or another confirmatory assessment would improve evaluation of kidney function.
Common pitfall: A normal creatinine concentration does not guarantee normal filtration. Avoid interpreting an estimate without considering muscle mass, clinical stability, and the decision it must support.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
5.Which changes suggest progression beyond expected variability?
Kidney measurements vary biologically and analytically, so a small change does not automatically indicate progression. KDIGO identifies a subsequent eGFR change greater than 20% as exceeding expected variability and warranting evaluation. A doubling of ACR likewise exceeds usual variability. Evaluate volume status, intercurrent illness, medication effects, and the measurement context before attributing the change to irreversible CKD progression. Trends become most useful when comparable measurements are interpreted alongside the patient's clinical course.
Apply it
A patient's stable eGFR falls from 50 to 38 after several days of vomiting. The change exceeds expected variability, but acute volume depletion needs evaluation before the decline is classified as chronic progression.
Common pitfall: Do not dismiss a substantial change as laboratory noise or assume it represents irreversible decline. Both shortcuts bypass potentially reversible explanations and needed reassessment.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
6.How does reduced filtration alter medication safety?
Reduced kidney clearance can increase exposure to a drug or its active metabolites, prolonging effects and increasing toxicity. Medication review therefore includes prescription medicines, over-the-counter products, supplements, current kidney function, and the drug-specific dosing method. A dose appropriate before an acute decline may become unsafe afterward. Conversely, unnecessary dose reduction can compromise treatment. Nursing assessment links symptoms, recent kidney changes, administration history, and monitoring results to a specific medication concern requiring correction.
Apply it
A patient with CKD becomes unusually sedated after an acute illness while continuing a renally cleared medicine. Compare current kidney function with the dosing plan and promptly communicate the suspected accumulation to the prescribing team.
Common pitfall: Do not apply one renal dose rule to every medicine. Clearance, active metabolites, therapeutic range, and the kidney function measure required by the drug differ.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
7.How should kidney changes after renin–angiotensin blockade be interpreted?
ACE inhibitors and ARBs reduce intraglomerular pressure, which can produce an early creatinine rise while providing longer-term kidney protection in appropriate patients. Blood pressure, creatinine, and potassium should be checked after initiation or dose escalation. KDIGO advises continuing therapy unless creatinine rises more than 30% within four weeks, while evaluating significant changes and other clinical concerns. Hyperkalemia often requires active management rather than reflex discontinuation, but symptomatic hypotension or uncontrolled hyperkalemia changes the decision.
Apply it
Two weeks after an ARB increase, a patient's creatinine rises 15%, potassium remains acceptable, and blood pressure is tolerated. Recognize that this finding alone does not justify stopping treatment; continue the prescribed monitoring plan.
Common pitfall: An expected hemodynamic change is not automatically nephrotoxicity. Equally, a large creatinine rise, symptomatic hypotension, or uncontrolled hyperkalemia should not be dismissed as harmless.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
8.When does SGLT2 inhibitor teaching require a temporary hold plan?
SGLT2 inhibitors provide kidney and cardiovascular benefits in eligible patients, and an initial reversible eGFR decrease does not usually require discontinuation. During prolonged fasting, surgery, or critical medical illness, however, ketosis risk makes temporary withholding reasonable. Teaching should identify these circumstances and explain the agreed restart plan. The decision distinguishes an expected early filtration effect from an illness-related safety concern; a patient needs actionable instructions rather than an indefinite instruction to stop whenever anything changes.
Apply it
A patient taking an SGLT2 inhibitor is preparing for surgery with prolonged fasting. Confirm the perioperative withholding and restart instructions with the treating team, and ask the patient to explain the plan in their own words.
Common pitfall: Do not confuse a modest initial eGFR dip with treatment failure. A temporary illness-related hold also needs a clear reassessment and restart plan.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
9.Why does CKD commonly cause anemia?
Healthy kidneys produce erythropoietin, which signals bone marrow to make red blood cells. Damaged kidneys may produce insufficient erythropoietin, reducing red cell production and oxygen-carrying capacity. Fatigue, exertional breathlessness, and reduced exercise tolerance can follow, but these symptoms are not specific to anemia. A complete blood count establishes whether anemia is present, while additional testing evaluates contributing causes. The mechanism explains an important association without making every low hemoglobin result attributable solely to CKD.
Apply it
A patient with advanced CKD reports increasing fatigue and exertional breathlessness. Review the complete blood count and anemia evaluation rather than assuming the symptoms reflect inadequate dialysis or recommending activity restriction as the only response.
Common pitfall: CKD-associated erythropoietin deficiency is common, but it is not a complete diagnosis. Iron deficiency, bleeding, inflammation, and other causes may coexist and require evaluation.
10.Which findings broaden an anemia investigation beyond erythropoietin deficiency?
Anemia in CKD can reflect reduced erythropoietin, inadequate available iron, blood loss, shortened red cell survival, or vitamin deficiencies. Evaluation therefore extends beyond the hemoglobin concentration to iron studies and other tests guided by the clinical picture. Ferritin reflects stored iron but can rise with inflammation, so it should not be interpreted in isolation. A falling hemoglobin with bleeding symptoms or an unexpected treatment response requires investigation of the cause rather than automatic escalation of anemia medication.
Apply it
A patient's hemoglobin continues to fall despite prescribed anemia therapy, and the patient reports dark stools. Promptly communicate the possible blood loss and support the ordered investigation instead of assuming that CKD alone explains the change.
Common pitfall: A higher ferritin does not always prove adequate usable iron during inflammation. Increasing erythropoietic treatment without investigating poor response can miss a correctable cause.
Anemia in Chronic Kidney Disease · KDIGO-2026-Anemia-in-CKD-Guideline.pdf
11.How does CKD produce mineral and bone disorder?
As kidney function declines, phosphate excretion and activation of vitamin D become impaired. These changes disrupt calcium and phosphate balance and stimulate compensatory hormonal responses, including increased parathyroid hormone. Persistent disturbances can alter bone turnover and contribute to vascular and soft-tissue calcification. Assessment therefore considers phosphate, calcium, parathyroid hormone, and the clinical context together. Bone pain or fractures are possible manifestations, but biochemical changes may develop before obvious symptoms, making longitudinal monitoring important.
Apply it
A patient with CKD has rising phosphate and parathyroid hormone over successive visits. Explain how impaired phosphate handling and vitamin D activation connect the findings, and reinforce the individualized treatment and monitoring plan.
Common pitfall: Do not reduce CKD mineral and bone disorder to low dietary calcium. Treating one isolated result without considering related trends can misrepresent the underlying disturbance.
12.Why are phosphate binders taken with food?
Phosphate binders act within the gastrointestinal tract, binding dietary phosphate so less is absorbed into the bloodstream. Their timing therefore needs to coincide with phosphate-containing meals or snacks according to the prescription. They do not remove phosphate already circulating in blood in the way dialysis removes solutes. Teaching should connect each prescribed dose to the patient's actual eating pattern, because taking every dose at an unrelated convenient time can undermine treatment despite apparently consistent medication use.
Apply it
A patient takes all prescribed binder tablets at bedtime but eats most food earlier in the day. Use the meal schedule to explain why the prescribed doses need to accompany food rather than remain clustered at bedtime.
Common pitfall: Medication adherence includes timing as well as tablet count. A binder taken far from food may provide little benefit for phosphate consumed at another time.
13.How should a kidney diet be individualized?
Nutrition decisions depend on CKD stage, treatment modality, laboratory findings, nutritional status, and the person's usual foods. Sodium reduction can support blood pressure and volume management, but potassium or phosphate restrictions should address demonstrated needs rather than become automatic bans. Protein advice also changes with clinical circumstances, including dialysis and growth. A renal dietitian helps translate targets into adequate meals that fit culture, resources, and appetite while avoiding preventable malnutrition from excessive restriction.
Apply it
A patient with stable potassium has stopped eating many fruits and vegetables after receiving a generic food list. Review current results and refer for individualized nutrition counseling that preserves adequate intake while addressing actual kidney-related risks.
Common pitfall: A universal list of forbidden foods can worsen intake without addressing the patient's problem. Laboratory trends and nutritional needs should guide specific restrictions and substitutions.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease · CKD and Diet: Assessment, Management, and Treatment
14.When should dialysis initiation be considered?
Dialysis initiation uses a composite assessment of symptoms, signs, quality of life, preferences, GFR, and laboratory abnormalities. Important indications include symptoms attributable to kidney failure, medically resistant electrolyte or acid–base abnormalities, inability to control volume or blood pressure, and progressive nutritional deterioration despite intervention. An eGFR value alone does not establish the need to begin immediately. Preparation and shared decision-making should occur early enough to avoid equating thoughtful planning with an urgent requirement to start treatment.
Apply it
One patient with a very low eGFR is eating well and has controlled volume and electrolytes; another has refractory pulmonary congestion. Recognize the second patient's clinical complication as a stronger immediate indication than filtration level alone.
Common pitfall: Do not choose a universal eGFR trigger or wait for every possible symptom. A serious refractory complication can justify treatment even without a predetermined filtration threshold.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
15.What does comprehensive conservative kidney care include?
Comprehensive conservative care is an active treatment pathway for people who choose management without dialysis or transplantation. It includes symptom relief, management of complications where consistent with goals, psychosocial and spiritual support, advance care planning, and coordinated communication. Decisions consider expected benefits, burdens, prognosis, and personal priorities. Choosing this pathway does not mean withdrawing all treatment or abandoning follow-up; nursing care remains directed toward comfort, function, informed choices, and support for the patient and family.
Apply it
A frail adult prioritizes remaining at home and declines dialysis after informed discussion. Help develop a symptom-management and follow-up plan, clarify emergency preferences, and involve the relevant supportive-care and community services with the patient's agreement.
Common pitfall: Do not present conservative care as simply doing nothing or assume family preferences replace the informed patient's goals. Active support remains central to the pathway.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
16.Why does pediatric growth influence kidney replacement decisions?
Children require assessment of growth and nutritional development in addition to adult-style biochemical and symptom measures. CKD can impair appetite, nutrition, and growth, with consequences for development that are not captured by eGFR alone. KDIGO identifies poor growth refractory to optimized nutrition, growth hormone, and medical management as an additional consideration for starting dialysis in children. Serial growth measurements and multidisciplinary evaluation distinguish a persistent kidney-related problem from an isolated measurement or a readily correctable nutritional issue.
Apply it
A child with advanced CKD has continued growth failure despite optimized nutrition and medical treatment. Escalate the growth trajectory for multidisciplinary kidney replacement assessment rather than waiting for an adult symptom pattern or a single eGFR threshold.
Common pitfall: Adult initiation cues are incomplete for children. Persistent growth failure deserves attention, but one low height measurement alone does not establish treatment failure or dialysis need.
17.How should adolescents prepare for adult kidney care?
Transition is a planned developmental process that builds self-management skills before transfer to adult services. Readiness includes understanding the diagnosis, medicines, appointments, warning signs, and how to obtain help or supplies. Families remain important, but responsibility should shift in supported steps appropriate to the adolescent's abilities. Coordination between pediatric and adult teams reduces gaps in care. Assessment of readiness and barriers is more informative than assuming that reaching a particular birthday establishes independent management.
Apply it
A teenager can name the diagnosis but relies on a parent for every refill. Practise requesting refills together, clarify insurance or access issues, and share progress with both teams before transferring responsibility for all medication management.
Common pitfall: A transfer appointment does not complete transition. Abruptly removing caregiver support or judging readiness by age alone can expose unrecognized gaps in practical self-management.
18.How does teach-back reveal an education gap?
Teach-back asks patients to explain a plan in their own words so the clinician can evaluate how clearly the information was communicated. It is more informative than asking whether the patient understands, which often produces an agreeable response without demonstrating comprehension. Use small amounts of plain-language information, invite explanation without blame, and reteach when needed. Incorporating the patient's language, customary meals, resources, and support system makes the corrected plan more usable in daily kidney care.
Apply it
After discussing a new fluid plan, ask the patient to describe how tomorrow's drinks will fit within it. If the explanation reveals confusion about soup or ice, clarify those examples and repeat the understanding check.
Common pitfall: Teach-back is not a memory test or a request to repeat jargon word for word. An incorrect explanation signals a need to improve teaching.
Teach-Back — Guide to Improving Patient Safety in Primary Care Settings
Acute In-patient Therapies25%
19.Which changes meet the diagnostic criteria for AKI?
KDIGO defines acute kidney injury by any of three findings: serum creatinine rising at least 0.3 mg/dL within 48 hours, increasing to at least 1.5 times baseline known or presumed within seven days, or urine output below 0.5 mL/kg/hour for six hours. These criteria identify changes over time rather than a single universal abnormal creatinine concentration. Urine output and creatinine provide complementary information, so preserved urine production does not exclude AKI when the creatinine criterion is met.
Apply it
A patient's creatinine increases from 0.9 to 1.3 mg/dL over 36 hours despite continued urine production. Recognize that the absolute increase meets an AKI criterion and begin evaluating the cause and associated risks.
Common pitfall: Do not wait for creatinine to exceed the laboratory reference range or for oliguria to develop. Either qualifying creatinine change can establish AKI independently.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
20.How is AKI severity staged when criteria disagree?
Use the most severe qualifying creatinine or urine-output criterion. Stage 1: creatinine 1.5–1.9 times baseline or an increase ≥0.3 mg/dL; or urine output <0.5 mL/kg/hour for 6–12 hours. Stage 2: creatinine 2.0–2.9 times baseline; or urine output <0.5 mL/kg/hour for ≥12 hours. Stage 3: creatinine ≥3 times baseline, an increase to ≥4.0 mg/dL in established AKI, initiation of kidney replacement therapy, or, in patients younger than 18 years, a decrease in eGFR to <35 mL/min/1.73 m²; urine-output criteria are <0.3 mL/kg/hour for ≥24 hours or anuria for ≥12 hours. Apply these within an established acute episode and document the qualifying criterion.
Apply it
During an acute episode, creatinine rises from 1.0 to 2.2 mg/dL, meeting stage 2, while measured urine output is 0.2 mL/kg/hour for 26 hours, meeting stage 3. Assign stage 3 because the urine-output criterion indicates the more severe stage.
Common pitfall: Do not average discordant stages or let preserved urine output cancel a creatinine-based stage. A chronically elevated creatinine alone does not establish acute stage 3 injury.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
21.How should sudden oliguria be investigated?
Low recorded urine output can reflect reduced kidney perfusion, intrinsic kidney injury, urinary obstruction, or a collection-system problem. Begin by confirming the measurement and assessing the patient rather than assuming a single cause. In a catheterized patient, inspect tubing and drainage, assess for retention as appropriate, and review hemodynamics, intake, losses, and recent exposures. Persistent or unexplained findings may require imaging and further investigation. Prompt differentiation matters because obstruction and perfusion problems can demand different interventions.
Apply it
A postoperative patient's urine output abruptly stops while blood pressure is unchanged. Inspect the collection tubing and assess for retention while reviewing the broader clinical picture, rather than automatically requesting a diuretic for presumed intrinsic kidney failure.
Common pitfall: A drainage obstruction can mimic anuria, but finding no tubing kink does not establish intrinsic AKI. Continue evaluating perfusion, retention, and other causes.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury · Renal Association Clinical Practice Guideline: Acute Kidney Injury, August 2019
22.When can fluid administration worsen AKI care?
Restoring circulating volume can improve kidney perfusion when true intravascular depletion is present, but oliguria alone is not proof that more fluid is needed. Continued fluid administration in an overloaded patient can worsen pulmonary edema and organ congestion without restoring filtration. Assessment integrates blood pressure, perfusion, losses, examination, fluid balance, and response to previous treatment. The nursing decision is to identify the volume problem and evaluate response, rather than treating every low urine measurement with the same fluid intervention.
Apply it
An oliguric patient has increasing oxygen needs, crackles, and a strongly positive fluid balance after repeated boluses. Escalate concern about overload and reassessment of the plan instead of assuming another bolus must improve kidney perfusion.
Common pitfall: Oliguria is not synonymous with dehydration. Conversely, peripheral edema alone does not fully describe intravascular volume; interpret findings together and reassess treatment response.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury · Renal Association Clinical Practice Guideline: Acute Kidney Injury, August 2019
23.Which AKI complications require urgent kidney replacement assessment?
Urgent kidney replacement therapy is indicated when life-threatening fluid, electrolyte, or acid–base disturbances cannot be controlled adequately with medical treatment. Examples include refractory hyperkalemia, severe refractory acidosis, and pulmonary edema compromising oxygenation. Uremic complications such as pericarditis or encephalopathy also warrant urgent assessment. Immediate stabilization and specialist coordination proceed together. The decisive feature is the dangerous complication and its response to treatment, rather than a creatinine value chosen as a universal emergency threshold.
Apply it
A patient with AKI remains severely hyperkalemic with recurrent electrocardiographic changes despite temporizing treatment. Continue emergency stabilization and activate urgent kidney replacement planning rather than waiting for a further increase in creatinine.
Common pitfall: Temporizing potassium redistribution does not remove the body's excess potassium. Do not mistake a short-lived laboratory improvement for definitive control when dangerous abnormalities recur.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury · Renal Association Clinical Practice Guideline: Acute Kidney Injury, August 2019
24.Why is one urea or creatinine value insufficient to time acute therapy?
Urea and creatinine concentrations reflect more than the immediate need for kidney replacement therapy. Their levels depend on production, distribution, clearance, and the timing of illness, and they do not directly quantify every dangerous complication. KDIGO recommends considering the broader clinical context, potentially modifiable conditions, and laboratory trends rather than isolated thresholds. A rising value may support concern, but oxygenation, potassium, acid–base status, uremic manifestations, and ongoing fluid requirements can be more decisive for timing.
Apply it
Two patients have similar creatinine concentrations. One is clinically stable; the other has refractory pulmonary edema and worsening oxygenation. Explain why the second patient's complication drives urgent treatment assessment even though the creatinine values are alike.
Common pitfall: Do not delay treatment because a preferred numerical threshold has not been reached, or start solely because a high value appears without evaluating clinical context.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
25.When is continuous therapy favored over intermittent hemodialysis?
Continuous kidney replacement therapy removes solute and fluid over an extended period, permitting slower changes than conventional intermittent hemodialysis. KDIGO suggests continuous therapy for hemodynamically unstable patients because rapid fluid and osmotic shifts may be poorly tolerated. Modality choice also depends on the clinical problem, resources, and local expertise. Continuous treatment does not eliminate hypotension or guarantee better survival; it offers a physiological approach suited to selected patients while still requiring close assessment of hemodynamics and delivered treatment.
Apply it
A patient requiring vasopressors needs kidney replacement therapy and ongoing fluid management. Anticipate discussion of a continuous modality to distribute removal over time, while continuing to assess perfusion and tolerance throughout the prescribed treatment.
Common pitfall: Do not interpret continuous therapy as inherently risk-free or universally superior. A stable patient with a different urgent clearance need may be better served by another modality.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury · Renal Association Clinical Practice Guideline: Acute Kidney Injury, August 2019
26.How does diffusion remove solute during kidney replacement therapy?
Diffusion moves dissolved particles across a semipermeable membrane down a concentration gradient. Dialysate maintains a lower concentration of selected waste solutes on the opposite side of the membrane, supporting transfer from blood. Small solutes are especially suited to this mechanism. Clearance depends on factors including membrane properties, flow, and the maintained gradient. Recognizing dialysate flow as the defining feature helps distinguish diffusive therapy from replacement-fluid-based convective therapy, while acknowledging that combined modalities use both mechanisms.
Apply it
During treatment review, a nurse sees dialysate passing along the opposite side of a membrane from the blood. Identify concentration-gradient-driven diffusion as the intended solute transport mechanism rather than attributing all clearance to fluid removal.
Common pitfall: Diffusion is solute movement, not simply water extraction. A treatment can provide substantial solute clearance while its prescribed net fluid removal is minimal or zero.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
27.How does convection differ from diffusion?
Convection carries solutes with water moving across a membrane under a pressure gradient, a process often called solvent drag. Hemofiltration uses this mechanism and administers replacement fluid to compensate for much of the filtered volume. Solute passage depends on membrane permeability and the solute's ability to cross it. This differs from diffusion, which depends primarily on a concentration gradient. In combined hemodiafiltration, both mechanisms contribute, so identifying the fluid pathways helps explain the prescription.
Apply it
A continuous therapy prescription includes substantial replacement fluid and filtration across the membrane. Explain that water movement carries permeable solutes, and distinguish this clearance process from the smaller net fluid loss prescribed for the patient.
Common pitfall: Replacement-fluid volume is not the patient's net fluid gain, and total filtration is not automatically net fluid removal. The circuit's full fluid accounting determines balance.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
28.Why must net ultrafiltration be separated from solute clearance?
Solute clearance describes removal of dissolved substances, whereas net ultrafiltration describes fluid removed from the patient after accounting for relevant circuit inputs. A continuous treatment may generate substantial effluent for solute clearance while replacement fluid offsets much of the filtered water. Separately prescribed net fluid removal then contributes to the patient's overall balance. Nursing assessment combines the machine prescription with intravenous intake, nutrition, urine, drains, and other losses rather than treating effluent volume as the patient's total fluid loss.
Apply it
A patient receiving continuous therapy has a large effluent volume but also receives replacement fluid and several intravenous infusions. Reconcile all inputs and outputs before deciding whether the patient achieved the intended negative balance.
Common pitfall: Effluent, net machine removal, and whole-patient balance are different quantities. Substituting one for another can substantially misrepresent whether congestion is improving or depletion is developing.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
29.How do treatment interruptions reduce delivered continuous therapy?
A prescribed continuous therapy dose assumes that treatment operates as intended, but clotting, procedures, access problems, and alarms reduce actual treatment time. For a simplified time-based calculation, a running dose of 25 mL/kg/hour delivered for 18 of 24 hours averages 18.75 mL/kg/hour over the day. This illustrates why a correct machine setting does not guarantee adequate delivered therapy. Review downtime, access function, and the prescription together, while recognizing that actual clearance also depends on additional treatment factors.
Apply it
A continuous circuit repeatedly stops during procedures, yet the running effluent rate remains unchanged. Calculate the time-adjusted delivery, document the interruptions and causes, and communicate the reduced treatment exposure so the team can address preventable downtime.
Common pitfall: Do not document the prescribed running rate as the delivered daily dose without considering downtime. Avoid independently increasing settings to compensate without an authorized prescription.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury · Renal Association Clinical Practice Guideline: Acute Kidney Injury, August 2019
30.How does acute kidney replacement therapy change medication review?
Medication exposure during AKI depends on residual kidney function, nonrenal clearance, distribution, and removal by the selected kidney replacement modality. Continuous treatment can remove some drugs throughout the day, while interruptions or modality changes can alter clearance again. Protein binding and molecular characteristics also influence removal. Review dosing with pharmacy and the treating team when therapy starts, stops, or changes, using drug-specific guidance and therapeutic monitoring where appropriate rather than assuming that a general kidney-failure dose remains correct.
Apply it
An antimicrobial regimen was selected during functioning continuous therapy, but the circuit has now been off for many hours. Notify pharmacy and the prescriber about the interruption so dosing and monitoring reflect the changed clearance conditions.
Common pitfall: Both accumulation and underexposure are possible. A medication plan appropriate for untreated kidney failure may be inadequate during active extracorporeal clearance, and vice versa.
Renal Association Clinical Practice Guideline: Acute Kidney Injury, August 2019 · KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
31.How does scrub-the-hub technique prevent catheter contamination?
A hemodialysis catheter hub provides a potential route for organisms to enter the bloodstream. CDC's protocol combines hand hygiene, appropriate gloves, aseptic handling, friction with an appropriate antiseptic, and complete drying before connection or access. The cleaned hub must remain protected from contact that would recontaminate it. Disinfection is an action performed at each relevant access event, not a property conferred permanently by a clean dressing or a prior treatment's preparation.
Apply it
After disinfecting a catheter hub, a nurse notices that it touches an unclean surface before connection. Treat the hub as recontaminated and repeat the required disinfection and drying process rather than relying on the earlier cleaning.
Common pitfall: A clean exit-site dressing does not disinfect the hub. Rushing the drying step or touching the prepared connection surface undermines the aseptic sequence.
32.What can diuretics accomplish during AKI?
Diuretics can help manage volume overload in selected patients with AKI, but they do not directly repair injured kidneys or reliably prevent the need for kidney replacement therapy. KDIGO advises against using them to prevent AKI or treating AKI with them except for volume-overload management. A rise in urine output after a diuretic therefore does not establish recovery of filtration. Evaluate congestion, hemodynamics, electrolyte effects, and kidney trends rather than treating urine volume alone as the therapeutic endpoint.
Apply it
An overloaded patient produces more urine after a prescribed loop diuretic, but potassium and creatinine remain concerning. Assess the improvement in congestion separately from kidney recovery and continue evaluation of whether other treatment is required.
Common pitfall: More urine is not proof that AKI has resolved. Do not use a diuretic response to dismiss persistent dangerous electrolyte abnormalities or other replacement-therapy indications.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
33.When should kidney status be reassessed after AKI?
AKI can resolve, leave persistent impairment, or increase future CKD risk, so discharge does not end kidney follow-up. KDIGO recommends evaluation at three months for resolution, new CKD, or worsening pre-existing CKD. Earlier review may be needed according to severity, residual abnormalities, and medication changes. Nursing handover should communicate the AKI episode, kidney trajectory, medicine adjustments, and follow-up responsibilities so the patient does not mistake improved symptoms for confirmation that kidney risk has disappeared.
Apply it
A patient leaving hospital after AKI feels well but has not returned to the previous creatinine baseline. Confirm earlier follow-up as indicated and a plan to reassess kidney status at three months, including who will review results.
Common pitfall: Three-month reassessment is not a reason to postpone necessary earlier monitoring. A seemingly recovered episode also deserves follow-up because subsequent kidney risk can remain elevated.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
Peritoneal Dialysis20%
34.How does a PD dwell remove dissolved waste?
During peritoneal dialysis, dialysate in the abdominal cavity exchanges solutes with blood across the peritoneal membrane. Waste solutes diffuse down concentration gradients into the dialysate, which is later drained and replaced. Dwell time influences the opportunity for exchange, but longer is not always better for every treatment goal because gradients change over time. Understanding fill, dwell, and drain helps distinguish inadequate exchange time from a drainage problem or an inappropriate fluid-removal expectation.
Apply it
A new patient thinks that immediately draining every fresh fill will remove more waste because more exchanges seem better. Explain why prescribed dwell time allows solute transfer and why exchange timing should follow the individualized regimen.
Common pitfall: The dialysate does not cleanse blood merely by entering the abdomen. Solute exchange requires time, and changing dwell duration can alter clearance and fluid removal.
35.Why does glucose-containing PD solution remove water?
Glucose in PD solution creates an osmotic gradient that draws water from the circulation across the peritoneal membrane into the abdominal cavity. Draining the used solution then removes that water from the body. Higher glucose concentrations generally provide a stronger initial osmotic effect, but glucose absorption and dwell duration change the gradient over time. Fluid balance therefore depends on the prescribed solution, dwell pattern, membrane characteristics, intake, and residual urine output rather than the solution concentration alone.
Apply it
A patient with falling drain volumes asks whether every exchange should use the strongest glucose solution. Review weight, intake, urine, exchange records, and the prescription with the PD team before attributing the problem to insufficient osmotic strength.
Common pitfall: Stronger glucose is not a universal solution to poor fluid removal. Mechanical drainage problems and prescription or intake issues can produce a similar clinical picture.
36.How do CAPD and automated PD differ?
Continuous ambulatory peritoneal dialysis uses manual exchanges distributed through the day, whereas automated PD uses a cycler to perform exchanges, commonly during sleep. Both depend on the same peritoneal membrane and require trained connection technique, appropriate supplies, and adherence to the individualized prescription. Automated treatment may still include a daytime dwell. Selection considers lifestyle, ability, support, and treatment requirements; use of a machine does not remove the need to recognize infection or respond to drainage difficulties.
Apply it
A patient assumes automated PD will eliminate all daytime treatment tasks. Review the actual prescription, including any daytime dwell, supply management, exit-site care, and what the patient must do if a cycler alarm interrupts treatment.
Common pitfall: Do not describe automated PD as maintenance-free or CAPD as a different physiological therapy. The delivery schedule changes, while core infection and exchange principles remain.
37.Which findings establish PD-associated peritonitis?
ISPD recommends diagnosing peritonitis when at least two of three criteria are present: compatible clinical features such as abdominal pain or cloudy effluent; effluent white cells above 100/µL after a dwell of at least two hours, with more than 50% neutrophils; and a positive effluent culture. Cloudy effluent requires prompt evaluation and presumptive management while confirmation proceeds. A culture result is not required before acting when clinical and cellular criteria already support the diagnosis.
Apply it
A patient reports cloudy drainage and abdominal pain. Effluent after a three-hour dwell contains 420 white cells/µL with 82% neutrophils. Recognize that clinical and cellular criteria support peritonitis even while the culture remains pending.
Common pitfall: Waiting for a positive culture can delay necessary treatment. Conversely, interpreting a cell count without its differential and dwell duration can misclassify the result.
ISPD Peritonitis Guideline Recommendations: 2022 Update on Prevention and Treatment
38.When should effluent sampling and initial treatment occur?
Suspected PD peritonitis requires prompt effluent collection for cell count, differential, and culture, followed immediately by empiric antibiotics covering both gram-positive and gram-negative organisms. The regimen is center-specific, accounting for local susceptibility patterns and patient factors. Intraperitoneal administration is preferred when drug compatibility and stability permit, unless systemic sepsis requires systemic treatment. If immediate intraperitoneal delivery is unavailable, begin appropriate systemic treatment rather than delay antibiotics, then arrange intraperitoneal therapy when feasible. Obtain specimens before antibiotics when this can be done promptly, but do not await laboratory results. Culture and susceptibility findings subsequently guide treatment refinement.
Apply it
A stable patient presents with cloudy effluent and abdominal pain. Collect effluent promptly and verify that prescribed empiric therapy covers both organism groups. Check intraperitoneal preparation compatibility and stability with pharmacy; if preparation would delay treatment, coordinate prompt systemic administration and subsequent intraperitoneal delivery.
Common pitfall: Neither culture collection nor arranging the preferred route should cause a prolonged treatment delay. Do not assume every antibiotic can be mixed in dialysate or that one universal regimen fits every center and patient.
ISPD Peritonitis Guideline Recommendations: 2022 Update on Prevention and Treatment
39.How does a short automated dwell change cell-count interpretation?
Effluent white cell concentration depends partly on how long dialysate remains in the abdomen. During rapid automated PD exchanges, a short dwell may produce a total white cell count below the usual 100/µL threshold despite peritonitis. ISPD therefore emphasizes the neutrophil percentage in this setting: more than 50% neutrophils is strong evidence supporting peritonitis even when the absolute count is lower. Interpret the result with symptoms, effluent appearance, dwell duration, and the remaining diagnostic evidence.
Apply it
After a short cycler dwell, a symptomatic patient's cloudy effluent contains 75 white cells/µL with 86% neutrophils. Flag the neutrophil predominance and short dwell rather than reassuring the patient solely because the total is below 100.
Common pitfall: The standard absolute cell threshold assumes sufficient dwell time. Applying it rigidly to rapid automated exchanges can falsely reassure clinicians and delay appropriate peritonitis management.
ISPD Peritonitis Guideline Recommendations: 2022 Update on Prevention and Treatment
40.Why does effluent culture technique affect peritonitis care?
Effluent culture identifies organisms and susceptibility patterns that can guide targeted treatment. ISPD recommends blood-culture bottles as the preferred method for bacterial culture of PD effluent, with appropriate collection and prompt laboratory handling. Poor sampling, delayed transport, or antibiotics given before collection can contribute to culture-negative episodes. A negative culture therefore does not automatically exclude clinically established peritonitis. Reviewing collection performance is a practical quality-improvement step when a program has unexpectedly frequent culture-negative results.
Apply it
A PD program notices repeated culture-negative episodes despite compatible symptoms and inflammatory effluent counts. Review collection timing, use of blood-culture bottles, and transport arrangements with the laboratory before concluding that the episodes were noninfectious.
Common pitfall: Culture negativity and absence of infection are not interchangeable. Good specimen handling improves organism identification, but treatment decisions still integrate clinical and cellular evidence.
ISPD Peritonitis Guideline Recommendations: 2022 Update on Prevention and Treatment
41.Which exit-site finding most strongly indicates infection?
ISPD defines a definitive PD catheter exit-site infection by purulent discharge at the catheter–epidermal interface, with or without surrounding erythema. Redness alone is less specific and may reflect irritation or early infection requiring assessment and follow-up. Examine the exit site and consider tenderness or changes along the tunnel, because infection can extend beyond the visible opening. Precise description of discharge and local findings is more useful than labeling every red area as an established bacterial infection.
Apply it
A patient has yellow purulent drainage at the catheter exit but little surrounding redness and no fever. Recognize that purulence supports an exit-site infection and arrange assessment rather than waiting for more extensive erythema.
Common pitfall: Absence of fever or marked redness does not exclude an exit-site infection with purulent drainage. Redness without purulence, however, is not equally specific.
ISPD Catheter-related Infection Recommendations: 2023 Update
42.Why can constipation impair PD outflow?
Constipation is a common reversible cause of PD catheter drainage dysfunction. A distended, stool-filled bowel can compress catheter drainage openings or displace the catheter from a favorable pelvic position. A bowel history therefore belongs in the initial assessment of poor outflow, together with inspection for external tubing problems. Management follows the prescribed bowel plan and reassessment of drainage. Persistent dysfunction despite correction requires further evaluation for causes such as migration, kinking, or tissue entrapment.
Apply it
A patient reports easy filling but slow drainage and no bowel movement for four days. Assess the bowel pattern and implement the prescribed constipation plan while checking the external system, then reassess whether drainage improves.
Common pitfall: Do not assume a poorly draining catheter requires immediate replacement. Constipation is often reversible, but persistent problems still need investigation rather than repeated unsupported home maneuvers.
Creating and Maintaining Optimal Peritoneal Dialysis Access in the Adult Patient: 2019 Update
43.How do inflow and outflow patterns localize a PD problem?
A catheter that fills normally but drains poorly suggests an outflow problem, while impaired flow in both directions raises concern for a different or more complete obstruction. Initial assessment checks clamps, tubing position, external kinks, bowel function, and the pattern's onset. Further evaluation may identify catheter displacement, intraluminal obstruction, or surrounding tissue interference. The flow pattern guides investigation; it does not by itself prove a single cause or justify forceful attempts to clear the catheter.
Apply it
A patient reports that neither filling nor draining is possible after reorganizing supplies. Check the external line and clamps first, then escalate unresolved dysfunction rather than assuming the new problem reflects inadequate dialysis solution strength.
Common pitfall: Distinguishing one-way from two-way dysfunction helps direct assessment but does not replace it. Do not force fluid against resistance or attribute all drainage problems to constipation.
Creating and Maintaining Optimal Peritoneal Dialysis Access in the Adult Patient: 2019 Update
44.How does absorbed dialysate glucose affect daily care?
Some glucose from PD solution crosses into the bloodstream during a dwell. It contributes energy intake and can raise blood glucose, particularly in people with diabetes. Nutrition and diabetes plans therefore need to account for dialysate exposure as well as food and medicines. Weight change must be interpreted carefully because it may reflect fluid, body tissue, or both. A change in solution use can alter glucose exposure, making coordinated review more useful than an isolated recommendation to eat less.
Apply it
A patient using more glucose-containing exchanges develops higher glucose readings without a major dietary change. Review the solution pattern with the PD and diabetes teams and consider absorbed glucose when reassessing monitoring and the nutrition plan.
Common pitfall: Dialysate glucose is not metabolically invisible because it enters through the abdomen. Avoid attributing every rise in glucose or weight to dietary nonadherence.
45.How is a PD program's peritonitis rate calculated?
Peritonitis incidence is expressed as episodes per patient-year at risk, allowing comparison across programs or periods with different exposure time. Divide the number of episodes by the accumulated patient-years, not simply by the number of people treated. ISPD's 2022 guidance recommends an overall rate no greater than 0.40 episodes per patient-year. Monitoring should also examine organisms, culture-negative episodes, and contributing processes so a rate becomes a basis for specific improvement rather than only a performance label.
Apply it
A service records six peritonitis episodes during 240 patient-months of PD exposure. Convert the denominator to 20 patient-years and calculate 0.30 episodes per patient-year, then review episode patterns to identify opportunities for prevention.
Common pitfall: Patient count is not equivalent to exposure time when treatment duration differs. A favorable overall rate can also conceal recurring organisms or preventable technique problems.
ISPD Peritonitis Guideline Recommendations: 2022 Update on Prevention and Treatment
Home Hemodialysis15%
46.When does a change in fistula thrill require action?
A functioning arteriovenous fistula usually has a palpable vibration, or thrill, reflecting blood flow through the access. Patients should learn the usual finding and check it regularly. An absent or clearly changed thrill can signal compromised flow and requires urgent contact with the dialysis or access team. The purpose is early recognition before the next planned cannulation, not independent diagnosis of the exact lesion. A comfortable arm and normal-looking skin do not establish that the access remains patent.
Apply it
Before a home session, a patient cannot feel the usual fistula vibration despite no pain or redness. Follow the urgent access-contact plan and obtain assessment rather than proceeding with routine cannulation or waiting until the next scheduled review.
Common pitfall: Do not use absence of pain as reassurance when the thrill disappears. Access dysfunction can be urgent even without fever, visible inflammation, or dramatic swelling.
47.How should the fistula arm be protected?
An arteriovenous fistula is a limited vascular access resource, so routine care aims to avoid unnecessary trauma and compression. Teaching includes avoiding blood pressure measurement, ordinary venipuncture, and constricting items on the access arm, while observing the site and maintaining hygiene. Protection does not mean never using the arm for normal activity; individualized advice accounts for healing and the person's circumstances. The practical cue is whether an action could compress flow, injure the access, or introduce infection.
Apply it
At an unrelated clinic visit, a patient is offered a blood pressure cuff on the fistula arm. Encourage the patient to identify the access and request an appropriate alternative site for measurement before the cuff is inflated.
Common pitfall: Do not assume other clinicians will automatically notice the fistula. Access protection requires clear communication, but it should not become a blanket prohibition on all arm movement.
48.What does prescribed dry weight represent?
Dry weight is an estimated postdialysis weight at which excess fluid has been removed without producing symptoms of excessive removal. It is a clinical target, not a permanently fixed measurement or a guarantee that every kilogram above it is safely removable in one session. Assessment includes blood pressure, edema, breathing, symptoms during treatment, and changes in body tissue. Illness, nutrition, or loss of muscle can change the appropriate target even when the scale appears familiar.
Apply it
A patient loses appetite and muscle over several weeks but continues using the old target weight. Review symptoms and fluid assessment with the home team because unchanged scale targets may now conceal excess extracellular fluid.
Common pitfall: Do not interpret all weight change as fluid or defend an old target despite new findings. Dry weight requires reassessment as body composition and clinical status change.
49.How is an educational ultrafiltration calculation constructed?
A simplified fluid-removal calculation begins with the prescribed net reduction in body fluid, then accounts for fluid entering and leaving during the session. If 2.0 L of net reduction is prescribed and 0.4 L will enter with no other losses, the machine must remove 2.4 L. Dividing by four treatment hours gives 0.6 L/hour. This arithmetic describes the supplied example; clinical tolerance, the actual prescription, and machine-specific instructions determine an appropriate treatment plan.
Apply it
For a four-hour session, the prescription specifies a 1.8 L net reduction and the supplied scenario includes 0.2 L intake with no other fluid changes. Calculate 2.0 L machine removal, averaging 0.5 L/hour.
Common pitfall: Do not omit intratreatment intake or treat a calculated hourly rate as universally safe. A correct arithmetic result does not independently authorize a prescription change.
50.Why can fluid removal cause cramps and hypotension?
During hemodialysis, water is removed from the circulation and must be replenished from other body compartments. If removal exceeds the patient's ability to maintain circulating volume, blood pressure may fall and symptoms such as dizziness, nausea, or cramps can develop. These findings require the trained response and review of the treatment plan. They are not a useful sign that dialysis is working especially well. Interdialytic intake, target weight, treatment duration, and removal goals all influence tolerance.
Apply it
A home patient repeatedly develops dizziness and cramps near the end of treatment. Review the episodes with the home team, including weight gains, removal settings, and target weight, instead of accepting the symptoms as an unavoidable treatment endpoint.
Common pitfall: Do not assume every symptom proves excessive removal, but do not normalize recurrent hypotension. Assessment should consider the full clinical picture and the prescribed emergency response.
51.How is home hemodialysis competency demonstrated?
Home hemodialysis training develops practical ability to prepare equipment, perform treatment steps, recognize problems, and respond according to the home program's instructions. Competency is demonstrated through observed performance and explanation, not attendance alone. Where a care partner is part of the arrangement, that person also needs the relevant skills. Training should connect routine technique with realistic troubleshooting and clear contact pathways so confidence is supported by demonstrated ability rather than familiarity with a machine's normal display.
Apply it
A learner can describe treatment setup but becomes unsure when a simulated alarm occurs. Continue supervised practice on the relevant response and help-seeking sequence before considering that skill independently mastered for treatment at home.
Common pitfall: Watching a procedure is not equivalent to performing it safely. A capable routine setup does not automatically demonstrate competence with alarms, interruptions, or emergency communication.
Hemodialysis · Teach-Back — Guide to Improving Patient Safety in Primary Care Settings
52.When is fistula bleeding an emergency?
A fistula carries high blood flow, so uncontrolled bleeding can become life-threatening rapidly. Patients and care partners need a rehearsed emergency plan, including applying firm direct pressure to the bleeding point and obtaining emergency assistance for severe or persistent bleeding. Recurrent prolonged bleeding after needle removal also merits access-team assessment even when each episode eventually stops. The distinction is between routine prescribed post-needle care and bleeding that is excessive, persistent, spontaneous, or accompanied by signs of deterioration.
Apply it
At home, a patient develops heavy access bleeding that does not settle with the taught initial pressure technique. Activate emergency assistance and maintain directed pressure according to the emergency plan rather than waiting for a routine clinic callback.
Common pitfall: Do not treat major access bleeding as a minor skin wound or delay emergency help while repeatedly changing dressings. High access flow can cause rapid blood loss.
53.Why does dialysis require specially controlled water?
Water acceptable for drinking is not automatically suitable for preparing hemodialysis fluid. Patients are exposed to large volumes across a dialysis membrane, making control of chemical contaminants, microorganisms, and endotoxins essential. Water-treatment systems and monitoring address different hazards; one reassuring test cannot substitute for all required checks. For home systems that use treated water, patients must follow program-specific operation, maintenance, and reporting procedures, including the response to a failed safety check before treatment begins.
Apply it
A home water system fails a required safety check, although the water looks clear and tastes normal. Follow the program's stop-and-contact instructions and arrange assessment rather than using appearance or drinking-water acceptability as evidence of dialysis safety.
Common pitfall: Clear water can contain clinically important chemical or microbial contamination. A normal microbial result also does not establish chemical safety or eliminate the need for endotoxin control.
54.How should a home schedule change be evaluated?
Home hemodialysis prescriptions can differ in session duration and frequency, which affects how fluid and solute removal are distributed through the week. A schedule must fit clinical needs as well as the person's home circumstances, training, and support. Missing or shortening treatment can alter clearance and fluid management even if the remaining sessions feel normal. Changes should be planned with the home team, with attention to medication, diet, monitoring, and the patient's ability to complete the revised regimen.
Apply it
A patient wants to combine several shorter home sessions into fewer longer sessions to accommodate work. Bring the goal to the home team for prescription review instead of assuming that equal weekly hours guarantee an equivalent treatment pattern.
Common pitfall: Total weekly hours alone do not capture treatment spacing or fluid accumulation between sessions. Convenience matters, but a changed schedule needs an individualized clinical plan.
Transplant10%
55.Where is a transplanted kidney placed and connected?
A transplanted kidney is generally placed in the lower abdomen rather than replacing a native kidney in its original location. Its blood vessels are connected to recipient vessels, and its ureter is connected to the bladder so urine can drain. Native kidneys usually remain unless there is a particular reason to remove them. This anatomy helps patients understand the operation and helps nurses interpret the location of the surgical wound, graft-related symptoms, and urinary drainage during recovery.
Apply it
A recipient asks why the incision is in the lower abdomen and whether both original kidneys must have been removed. Explain the graft's usual location, its bladder connection, and that native kidneys commonly remain in place.
Common pitfall: Do not infer graft location from native kidney anatomy. A transplant usually adds a functioning kidney in the lower abdomen rather than automatically removing both native kidneys.
56.Why must immunosuppression continue when a recipient feels well?
The recipient's immune system can recognize the transplanted kidney as foreign even when the graft functions well and the person has no symptoms. Immunosuppressive medicines reduce this rejection response and must be taken consistently according to the transplant regimen. Feeling well is therefore not evidence that treatment is no longer necessary. Teaching should connect each medicine to its purpose, explain the team's instructions for missed doses or illness, and emphasize contacting the team before making changes because of adverse effects.
Apply it
A recipient stops an immunosuppressant because creatinine is stable and the medicine causes bothersome symptoms. Explain the continuing rejection risk and arrange prompt transplant-team review of the symptoms and missed treatment rather than endorsing self-discontinuation.
Common pitfall: Normal results while taking treatment do not prove treatment is unnecessary. Skipping doses to reduce side effects can jeopardize the graft before obvious symptoms develop.
57.How should medication access barriers be addressed after transplant?
Consistent immunosuppression requires a reliable supply as well as understanding and motivation. Cost, insurance changes, transportation, language, complicated schedules, and adverse effects can all interrupt treatment. A useful adherence assessment asks specifically about these barriers without blame and connects the recipient with the transplant coordinator, pharmacist, social worker, or other support. The immediate goal is a workable supply and administration plan; repeating the importance of adherence alone cannot resolve a medicine the patient cannot obtain.
Apply it
A recipient reports stretching tablets because insurance coverage changed. Notify the transplant team promptly, clarify the remaining supply, and involve pharmacy and social work to secure continuity rather than merely instructing the patient to try harder.
Common pitfall: Do not equate a refill gap with lack of concern for the graft. Identify the specific barrier and avoid advising unsupervised dose rationing as a temporary solution.
58.When does unexplained graft dysfunction call for biopsy assessment?
A persistent unexplained rise in creatinine after transplantation requires evaluation because rejection is only one possible cause. Volume problems, obstruction, medication effects, and other graft disorders may produce similar laboratory changes. KDIGO recommends allograft biopsy for a persistent unexplained increase in serum creatinine, with clinical evaluation addressing reversible explanations. Tissue examination can distinguish processes that need different treatments. Nursing care supports accurate medication history, ordered testing, timely communication, and biopsy preparation rather than diagnosing rejection from creatinine alone.
Apply it
A recipient's creatinine remains elevated after volume assessment, medication review, and imaging show no explanation. Anticipate biopsy evaluation to identify the cause instead of assuming that a stable drug level excludes important graft pathology.
Common pitfall: A creatinine rise is a signal of dysfunction, not a tissue diagnosis. Empirically labeling every rise as rejection can obscure obstruction, toxicity, or other treatable causes.
KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients: A Summary
59.How does immunosuppression change infection vigilance?
Immunosuppressive treatment protects the graft by reducing immune activity, but it also increases susceptibility to infection. Recipients need a clear plan for reporting fever, urinary symptoms, respiratory symptoms, wound changes, or other signs of illness. Infection and rejection can both be associated with deteriorating graft function, so symptoms and laboratory changes require evaluation rather than self-directed changes to immunosuppression. Preventive medicines, monitoring, hygiene, and vaccination planning are coordinated with the transplant team according to the person's risks.
Apply it
A recipient develops fever and urinary discomfort with a higher creatinine. Arrange prompt transplant-team assessment for infection and graft dysfunction rather than assuming rejection or advising the patient to stop immunosuppression while waiting for symptoms to settle.
Common pitfall: Do not view infection risk as a reason for unsupervised immunosuppressant withdrawal. A new creatinine rise also cannot distinguish infection from rejection without further assessment.
Kidney Transplant · KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients: A Summary
60.Why does transplant follow-up include cancer prevention?
Long-term immunosuppression increases the risk of certain cancers, including skin cancer, so successful transplantation does not end preventive care. Education includes reducing sun exposure, using appropriate skin protection, reporting suspicious skin changes, and following the transplant team's screening recommendations. Prevention is integrated with graft monitoring and routine health maintenance rather than postponed until symptoms appear. Explaining the mechanism helps recipients understand why a functioning kidney and good laboratory results do not remove the need for ongoing surveillance.
Apply it
A recipient with excellent graft function reports a new skin lesion that repeatedly bleeds. Encourage prompt assessment and reinforce the established skin-protection and screening plan rather than reassuring the patient based on normal kidney laboratory results.
Common pitfall: Good graft function does not measure cancer risk. Do not dismiss a persistent changing lesion or assume that general sun exposure habits remain appropriate after transplantation.
Kidney Transplant · KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients: A Summary
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Use the official five-domain proportions to distribute study time, then increase attention to unfamiliar practice settings.
- Connect every clinical problem to a discriminating cue: chronicity, refractory complications, dwell duration, access flow, treatment exposure, or persistent unexplained graft dysfunction.
- Practise medication reasoning across changing kidney function and treatment modalities, including timing, accumulation, extracorporeal removal, and access barriers.
- Separate diffusion, convection, osmosis, net ultrafiltration, and whole-patient fluid balance before attempting calculations.
- Integrate infection prevention, teach-back, psychosocial needs, interdisciplinary collaboration, and quality improvement throughout modality study.
- Use pediatric growth and adolescent readiness as distinct assessment concerns rather than applying adult thresholds and assumptions unchanged.
A practical preparation plan
1. Map the complete outline
Read the September 1, 2026 specifications and blueprint. Create five study sections weighted 30%, 25%, 20%, 15%, and 10%, and track the seven cross-cutting objectives within them.
2. Build a clinical comparison sheet
Compare CKD with AKI, urgent with planned kidney replacement, diffusion with convection, PD peritonitis with exit-site infection, and graft dysfunction with confirmed rejection. Record the finding that separates each pair.
3. Work the quantitative examples
Calculate creatinine change, timed urine output, time-adjusted continuous therapy delivery, PD episodes per patient-year, and supplied fluid-removal examples. State units and assumptions before calculating.
4. Rehearse teaching and safety decisions
Explain binder timing, sick-day medication plans, fistula warning signs, cloudy effluent reporting, and immunosuppressant continuity using plain language. Use teach-back or observed demonstration to identify gaps.
5. Complete and review the drills
Answer the 20 questions before reading explanations. For each error, identify the decisive cue and explain why the tempting alternative fails. Use the flashcards later to retrieve the underlying mechanism.
6. Close gaps beyond this guide
Return to the full official outline and its recommended references for topics needing greater depth. Seek structured learning in less familiar nephrology settings and reassess understanding across all domains.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- CNN — Nephrology Nursing Certification Commission
- New Test Blueprint: Certified Nephrology Nurse (CNN) Examination
- Certified Nephrology Nurse Examination (CNN): Weights for Blueprint Categories
- Certification Examination Application Booklet
- Important Information Regarding CNN and CDN Examination Changes
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
- Executive Summary of the KDIGO 2024 CKD Guideline
- Anemia in Chronic Kidney Disease
- Mineral & Bone Disorder in Chronic Kidney Disease
- CKD and Diet: Assessment, Management, and Treatment
- Teach-Back — Guide to Improving Patient Safety in Primary Care Settings
- Acute Kidney Injury and Acute Kidney Disease — KDIGO
- KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
- Renal Association Clinical Practice Guideline: Acute Kidney Injury, August 2019
- Hemodialysis Central Venous Catheter Scrub-the-Hub Protocol
- ISPD Peritonitis Guideline Recommendations: 2022 Update on Prevention and Treatment
- Peritoneal Dialysis
- Creating and Maintaining Optimal Peritoneal Dialysis Access in the Adult Patient: 2019 Update
- ISPD Catheter-related Infection Recommendations: 2023 Update
- Fistula Care — National Kidney Federation
- Hemodialysis
- Water Use in Dialysis
- Kidney Transplant
- KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients: A Summary
- KDIGO-2026-Anemia-in-CKD-Guideline.pdf
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.